Objectives: A post-marketing surveillance (PMS) study was conducted to evaluate the efficacy and tolerability of treatment with moxifloxacin 400mg once daily in patients with acute exacerbations of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results